Global Artificial Organ Bank Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Product;

Artificial Organ and Bionic.

By Technology;

Mechanical Bionics and Electronic Bionics.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn657678967 Published Date: May, 2024 Updated Date: June, 2024

Introduction

Global Artificial Organ Bank Market (USD Million), 2020 - 2030

In the year 2023, the Global Artificial Organ Bank Market was valued at USD 5,141.14 million. The size of this market is expected to increase to USD 7,781.57 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.

The Global Artificial Organ Bank Market represents a pioneering frontier in the realm of medical innovation and healthcare accessibility. Artificial organs have emerged as transformative solutions for addressing critical gaps in organ transplantation, offering hope to millions of patients worldwide grappling with organ failure and chronic medical conditions. This market is driven by a convergence of advanced technologies, scientific breakthroughs, and a pressing need to overcome the limitations of traditional organ donation systems.

Artificial organ banks serve as vital repositories for a diverse array of bioengineered organs and tissues, ranging from hearts and kidneys to lungs and livers. These facilities harness the power of regenerative medicine, tissue engineering, and biomaterials science to fabricate functional substitutes for damaged or diseased organs. By providing a ready supply of bioartificial organs, these banks mitigate the scarcity of donor organs and reduce the burden on transplant waiting lists, offering renewed hope for patients awaiting life-saving interventions.

The market for artificial organ banks is characterized by a dynamic ecosystem of research institutions, biotechnology companies, medical device manufacturers, and healthcare providers collaborating to advance the frontiers of organ replacement therapies. Breakthroughs in 3D bioprinting, organ-on-a-chip technology, and immunomodulatory strategies have propelled the development of bioengineered organs with unprecedented levels of complexity, functionality, and compatibility.

In recent years, the global artificial organ bank market has witnessed remarkable progress in the development and commercialization of bioartificial organs across a spectrum of medical specialties. From bioengineered skin grafts for burn victims to bioartificial pancreases for diabetes management, these innovations hold the promise of revolutionizing patient care and improving quality of life for individuals facing debilitating health conditions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Technology
    3. Market Snapshot, By Region
  4. Global Artificial Organ Bank Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of chronic diseases
        2. Growing awareness about organ donation
        3. Rising geriatric population
        4. Improvements in healthcare infrastructure
        5. Innovative immunosuppressive therapies
      2. Restraints
        1. Organ shortage and waiting times
        2. Risk of organ rejection
        3. Limited skilled healthcare professionals
        4. Challenges in tissue compatibility
      3. Opportunities
        1. Alternative approaches like xenotransplantation
        2. AI in organ allocation and matching
        3. Research in organ preservation
        4. 3D bioprinting for personalized organs
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Artificial Organ Bank Market, By Product, 2020 - 2030 (USD Million)
      1. Artificial Organ
      2. Bionic
    2. Global Artificial Organ Bank Market, By Technology, 2020 - 2030 (USD Million)
      1. Mechanical Bionics
      2. Electronic Bionics
    3. Global Artificial Organ Bank Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Organovo Holdings, Inc.
      2. CELLINK
      3. Aspect Biosystems
      4. EnvisionTEC
      5. RegenHU
      6. 3D Systems Corporation
      7. Poietis
      8. Rokit Healthcare
      9. Nano Dimension Ltd.
      10. Cyfuse Biomedical K.K.
      11. TeVido BioDevices
      12. BioBots
      13. Bioprinting Solutions
      14. REGENHU Ltd.
      15. Axial3D
  7. Analyst Views
  8. Future Outlook of the Market